VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
GnRH-R-Targeted Lytic Peptide Sensitizes BRCA Wild-type Ovarian Cancer to PARP Inhibition.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
GnRH-R-Targeted Lytic Peptide Sensitizes BRCA Wild-type Ovarian Cancer to PARP Inhibition.
GnRH-R-Targeted Lytic Peptide Sensitizes BRCA Wild-type Ovarian Cancer to PARP Inhibition. Mol Cancer Ther. 2019 05; 18(5):969-979.
View in:
PubMed
subject areas
Animals
BRCA1 Protein
Cell Proliferation
Cisplatin
DNA Damage
Doxorubicin
Drug Resistance, Neoplasm
Female
Gene Expression Regulation, Neoplastic
Humans
Mice
Ovarian Neoplasms
Paclitaxel
Peptides
Phthalazines
Piperazines
Poly(ADP-ribose) Polymerase Inhibitors
Receptors, LHRH
Xenograft Model Antitumor Assays
authors with profiles
ANIL K SOOD
PRAHLAD RAM
LINGEGOWDA SELANERE MANGALA
MARK SEUNGWOOK KIM
ROBERT COLEMAN
SUNILA PRADEEP
SHERRY WU
KATHARINA SCHLACHER